New £400,000 melanoma vaccine heralds start of 'cancer renaissance' as UK trials personalised jabs for lung, bowel, pancreas and liver tumours but experts fear NHS can't afford them
dailym.ai -

The UK is entering a ' cancer renaissance' with pioneering personalised vaccines to combat some of the deadliest tumours expected by 2030, say leading experts.

Related Articles

Latest in News

More from dailym.ai | dailymail health NHS Cancer